Evidence map›Paper›PMID 12189208›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2002

Identification of a transcriptionally active peroxisome proliferator-activated receptor alpha -interacting cofactor complex in rat liver and characterization of PRIC285 as a coactivator.

Sailesh Surapureddi, Songtao Yu, Hengfu Bu, Takashi Hashimoto, Anjana V Yeldandi, Papreddy Kashireddy, Mustapha Cherkaoui-Malki, Chao Qi, Yi-Jun Zhu, M Sambasiva Rao and 1 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 136 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. HELZ2 RegulatesCirculation · 2026
    Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review article: vascular effects of PPARs in the context of NASH.Alimentary pharmacology & therapeutics · 2022
    Review
  17. Review
  18. Review
  19. Review
  20. Review

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Sailesh SurapureddiDepartment of Pathology, Northwestern University, The Feinberg School of Medicine, Chicago, IL 60611, USA.
Songtao Yu
Hengfu Bu
Takashi Hashimoto
Anjana V Yeldandi
Papreddy Kashireddy
Mustapha Cherkaoui-Malki
Chao Qi
Yi-Jun Zhu
M Sambasiva Rao
Janardan K Reddy
Northwestern University · USUniversity of California, Davis · US

Funding

Biologic Studies with Peroxisome Proliferators and PPARsR01GM023750 · NIGMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI REDDY, JANARDAN K. · 1985 to 2008
$4.0M
PEROXISOME PROLIFERATOR INDUCED HEPATOCARCINOGENESISR01CA084472 · NCI · NORTHWESTERN UNIVERSITY · PI RAO, SAMBASIVA M · 2000 to 2004
$1.2M
BIOLOGICAL STUDIES WITH LIVER PEROXISOME PROLIFERATORSR37GM023750 · NIGMS · NORTHWESTERN UNIVERSITY · PI REDDY, JANARDAN K. · 1987 to 1996
–
NCI NIH HHS CA84472NCI NIH HHS R01 CA084472NIGMS NIH HHS GM23570NIGMS NIH HHS R01 GM023750NIGMS NIH HHS R37 GM023750
6 · The paper itself

Abstract

Peroxisome proliferator-activated receptor alpha (PPAR alpha) plays a central role in the cell-specific pleiotropic responses induced by structurally diverse synthetic chemicals designated as peroxisome proliferators. Transcriptional regulation by liganded nuclear receptors involves the participation of cofactors that form multiprotein complexes to achieve cell- and gene-specific transcription. Here we report the identification of such a transcriptionally active PPAR alpha-interacting cofactor (PRIC) complex from rat liver nuclear extracts that interacts with full-length PPAR alpha in the presence of ciprofibrate, a synthetic ligand, and leukotriene B(4), a natural ligand. The liganded PPAR alpha-PRIC complex enhanced transcription from a peroxisomal enoyl-CoA hydratase/l-3-hydroxyacyl-CoA dehydrogenase bifunctional enzyme gene promoter template that contains peroxisome proliferator response elements. Rat liver PRIC complex comprises some 25 polypeptides, and their identities were established by mass spectrometry and limited sequence analysis. Eighteen of these peptides contain one or more LXXLL motifs necessary for interacting with nuclear receptors. PRIC complex includes known coactivators or coactivator-binding proteins (CBP, SRC-1, PBP, PRIP, PIMT, TRAP100, SUR-2, and PGC-1), other proteins that have not previously been described in association with transcription complexes (CHD5, TOG, and MORF), and a few novel polypeptides designated PRIC300, -285, -215, -177, and -145. We describe the cDNA for PRIC285, which contains five LXXLL motifs. It interacts with PPAR alpha and acts as a coactivator by moderately stimulating PPAR alpha-mediated transcription in transfected cells. We conclude that liganded PPAR alpha recruits a distinctive multiprotein complex from rat liver nuclear extracts. The composition of this complex may provide insight into the basis of tissue and species sensitivity to peroxisome proliferators.

Indexed as

Transcription, GeneticAmino Acid SequenceAnimalsCloning, MolecularDNA, ComplementaryLiverMaleMolecular Sequence DataRatsRats, Inbred F344Receptors, Cytoplasmic and NuclearTrans-ActivatorsTranscription FactorsDNA, ComplementaryHelz2 protein, ratReceptors, Cytoplasmic and NuclearTrans-ActivatorsTranscription Factors

Identifiers

PMID12189208
PMCPMC129355
OpenAlexW2136359444

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.